Champions Oncology (CSBR) Cash & Equivalents Growth (1y) (2011 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -6.38% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 985.02% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 137.81% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 5.03% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 107.64% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 33.56% |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -58.47% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -57.38% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 49.53% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -57.38% |
| Apr 30, 2026 | -50.21% |
| Jan 31, 2026 | 122.58% |
| Oct 31, 2025 | 209.22% |
| Jul 31, 2025 | 257.02% |
| Apr 30, 2025 | 273.76% |
| Jan 31, 2025 | -28.84% |
| Oct 31, 2024 | -50.05% |
| Jul 31, 2024 | -40.98% |
| Apr 30, 2024 | -74.13% |
| Jan 31, 2024 | -61.36% |
| Oct 31, 2023 | -49.08% |
| Jul 31, 2023 | -39.51% |
| Apr 30, 2023 | 12.33% |
| Jan 31, 2023 | 33.84% |
| Oct 31, 2022 | 125.54% |
| Jul 31, 2022 | 102.50% |
| Apr 30, 2022 | 92.17% |
| Jan 31, 2022 | 17.12% |
| Oct 31, 2021 | -44.19% |